GLP-1 receptor agoniststhink semaglutide, liraglutide, dulaglutide, exenatide, pramlintideare originally designed to help regulate blood sugar by mimicking the incretin hormones
The importance of long-term continuous use is amplified by STEP 4 [23] with semaglutide and SURMOUNT 4 [24] with tirzepatide
Weight loss can happen, but it is not the main reason for taking Ozempic
Purpose-built for physicians Adults prescribed semaglutide may have increased risk for form of optic neuropathy Key takeaways: Adults prescribed semaglutide were more likely to develop nonarteritic anterior ischemic optic neuropathy than those using non-GLP-1 medications
liver enzyme alterations are very frequent in PAC treated patients, even at routine dosage
Ozempic, Wegovy, and Mounjaro are FDA-approved medications